Identification of genes associated with relapse of prostate cancer and gene therapy

与前列腺癌复发相关的基因鉴定和基因治疗

基本信息

  • 批准号:
    13671640
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

We inoculated LNCaP cells, androgen-sensitive human prostate cancer cells, onto 5-week aged scid mice subcutneously with 50 % matrigel. After tumor was increased visually, we castrated the mouse. First, tumor retarded for 2 weeks. Then it stated to enlarge. We sacrificed the mouse and took the tumor and subcultured. (LN-RECO). Next we inoculated the LN-RECO to the castrated mouse. Again we took the enlarged tumor and subcultured (LN-REC4).We characterized LN-REC4 cells. Although LN-REC4 cells were stimulated by androgen in vitro, the growth speed of those cells in the castrated mouse was faster than LNCaP cells, suggesting that LN-REC4 seemed to be a good model that reflect the relapse of prostate cancer.We also investigated the COX-2 gene since this gene seemed to be related with progression of prostate cancer. Overexpression of COX-2 gene in LNCaP cells induced cell proliferation in vitro and in vivo, and induced VEGF secretion.
我们将LNCaP细胞,雄激素敏感的人前列腺癌细胞,用50%基质胶皮下接种到5周龄scid小鼠上。待肿瘤明显增大后,将小鼠去势。首先,肿瘤延迟2周。然后它说要扩大。我们处死小鼠,取出肿瘤并进行传代培养。(LN-RECO)。接下来,我们将LN-RECO接种到去势小鼠。我们再次取出扩大的肿瘤并进行传代培养(LN-REC 4)。我们对LN-REC 4细胞进行了表征。虽然LN-REC 4细胞在体外被雄激素刺激,但其在去势小鼠体内的生长速度比LNCaP细胞快,这表明LN-REC 4细胞似乎是一个很好的反映前列腺癌复发的模型。考克斯-2基因在LNCaP细胞中的过表达在体外和体内均诱导细胞增殖,并诱导VEGF分泌。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fujita, H., Koshida, K., Keller, E.T., Takahashi, Y., Yoshimoto, T., Namiki, M., Mizokami, A: "Cyclooxygenase-2 promotes prostate cancer progression"The prostate. 53. 232-240 (2002)
Fujita, H.、Koshida, K.、Keller, E.T.、Takahashi, Y.、Yoshimoto, T.、Namiki, M.、Mizokami, A:“Cyclooxygenase-2 促进前列腺癌进展”前列腺。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujita, H., Koshida, K., Keller, E. T., Takahashi, Y., Yoshimito, T., Namiki, M., Mizokami, A: "Cyclooxygenase-2 promotes prostate cancer progression"The prostate. 53. 232-240 (2002)
Fujita, H.、Koshida, K.、Keller, E. T.、Takahashi, Y.、Yoshimito, T.、Namiki, M.、Mizokami, A:“Cyclooxygenase-2 促进前列腺癌进展”前列腺。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Cyclooxygenase-2 promotes prostate cancer progression
  • DOI:
    10.1002/pros.10152
  • 发表时间:
    2002-11-01
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Fujita, H;Koshida, K;Mizokami, A
  • 通讯作者:
    Mizokami, A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIZOKAMI Atsushi其他文献

MIZOKAMI Atsushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIZOKAMI Atsushi', 18)}}的其他基金

The development of the innovative therapeutic drugs which targete crosstalk in the prostate cancer microenvironment
针对前列腺癌微环境串扰的创新治疗药物的开发
  • 批准号:
    17H04325
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Prevention of CRPC and application for docetaxel treatment using flavonoids
CRPC的预防及黄酮类多西紫杉醇治疗的应用
  • 批准号:
    25462472
  • 财政年份:
    2013
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of androgen-response genes related with the proliferation and development of proliferation-related marker in prostate cancer
前列腺癌中与增殖相关的雄激素反应基因和增殖相关标志物的发育的鉴定
  • 批准号:
    21592037
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of progression-related genes in prostate cancer and application to treatment
前列腺癌进展相关基因的鉴定及其在治疗中的应用
  • 批准号:
    17591669
  • 财政年份:
    2005
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of cyclooxygenase-2 and lipoxygenase on progression of prostate cancer
环氧合酶-2和脂氧合酶对前列腺癌进展的影响
  • 批准号:
    15591676
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of mechanism for VEGF expression in renal cell carcinoma
肾细胞癌中VEGF表达的机制分析
  • 批准号:
    08671852
  • 财政年份:
    1996
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Mechanism of loss of androgen dependency in prostate cancer, related to its proliferation and expansion
前列腺癌雄激素依赖性丧失的机制与其增殖和扩张有关
  • 批准号:
    10470335
  • 财政年份:
    1998
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了